Get the Stockscreener App
21.62
3.58%
0.89
Procept Biorobotics Corp stock is traded at $21.62, with a volume of 120.04K.
It is up +3.58% in the last 24 hours and up +15.94% over the past month.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
See More
Previous Close:
$20.73
Open:
$20.77
24h Volume:
120.04K
Relative Volume:
0.08
Market Cap:
$1.23B
Revenue:
$322.02M
Net Income/Loss:
$-102.47M
P/E Ratio:
-11.82
EPS:
-1.8295
Net Cash Flow:
$-80.57M
1W Performance:
-0.82%
1M Performance:
+15.94%
6M Performance:
-21.26%
1Y Performance:
-45.43%
1-Day Range:
$20.77
$21.55
1-Week Range:
$20.69
$22.20
52-Week Range:
$16.66
$42.43
Procept Biorobotics Corp Stock (PRCT) Company Profile
Name
Procept Biorobotics Corp
Sector
Industry
Phone
(650) 232-9832
Address
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
21.55 | 1.25B | 322.02M | -102.47M | -80.57M | -1.8295 |
ABT
Abbott Laboratories
|
115.73 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.00 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.61 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.87 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.91 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Initiated | Robert W. Baird | Neutral |
| Feb-26-26 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-26-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-12-25 | Initiated | UBS | Buy |
| Dec-08-25 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-02-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-09-25 | Initiated | Stephens | Overweight |
| Jul-07-25 | Initiated | Oppenheimer | Perform |
| Dec-02-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Initiated | Jefferies | Hold |
| Aug-11-23 | Initiated | Piper Sandler | Overweight |
| May-31-23 | Initiated | William Blair | Outperform |
| Oct-31-22 | Initiated | BTIG Research | Neutral |
| Oct-25-22 | Initiated | Truist | Buy |
| Sep-02-22 | Initiated | Wells Fargo | Overweight |
| Jul-15-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Goldman | Neutral |
| Oct-11-21 | Initiated | Guggenheim | Buy |
| Oct-11-21 | Initiated | SVB Leerink | Outperform |
View All
Procept Biorobotics Corp Stock (PRCT) Latest News
PROCEPT BioRobotics Corporation (PRCT) Investors: September 22, 2026 Filing Deadline in Securities Class ActionContact Lieff Cabraser - marketscreener.com
PROCEPT BioRobotics Corporation $PRCT Shares Purchased by Bank of America Corp DE - MarketBeat
PRCT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PROCEPT BioRobotics Corporation Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Kaplan Fox & Kilsheimer LLP Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors to Contact the Firm Before September 22, 2026 - The Globe and Mail
Deadline Alert: PROCEPT BioRobotics Corporation (PRCT) - GlobeNewswire
PRCT DEADLINE: SueWallSt Reminds PROCEPT BIOROBOTICS CORPORATION Investors of Upcoming Securities Class Action Deadline - PR Newswire
PRCT INVESTOR DEADLINE: RGRD Law Files Class Action Lawsuit Against PROCEPT BioRobotics Corporation and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit Before September 22, 2026 Deadline - marketscreener.com
PRCT INVESTOR DEADLINE: RGRD Law Files Class Action Lawsuit - GlobeNewswire
PROCEPT BioRobotics Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PROCEPT BioRobotics Corporation of Class Action Lawsuit and Upcoming DeadlinesPRCT - PR Newswire
PROCEPT BioRobotics Corporation (PRCT) Investors: September 22, 2026 Lead Plaintiff Deadline in Class Action Lawsuit - TradingView
PROCEPT BIOROBOTICS CORPORATION (PRCT) SHAREHOLDER ALERT - GlobeNewswire
PRCT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PROCEPT BioRobotics Corporation Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
PRCT DEADLINE: Levi & Korsinsky Reminds PROCEPT BIOROBOTICS CORPORATION Investors of Upcoming Securities Class Action Deadline - YCharts
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - TMX Newsfile
PRCT INVESTOR REMINDER: PROCEPT BioRobotics Corporation Investors Have Until September 22, 2026 To Contact Kirby McInerney LLP to Seek Lead Plaintiff Role - Business Wire
Kaplan Fox Announces a Securities Class Action Filed Against PROCEPT BioRobotics Corporation (NASDAQ: PRCT)Lead Plaintiff Deadline is September 22, 2026 - The Globe and Mail
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock DeclineInvestors May Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP - TMX Newsfile
Attention Long-Term Shareholders of AeroVironment, Inc. - GlobeNewswire
PRCT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PROCEPT BioRobotics Corporation Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
PRCT DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages PROCEPT BioRobotics ... - Caledonian Record
PRCT DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, - GlobeNewswire
Procept BioRobotics CEO Buys 23,900 Shares Amid 48% Stock Decline. What Does This Tell Investors? - The Motley Fool
Procept BioRobotics CEO Buys 23,900 Shares Amid 48% Stock Decline. What Does This Tell Investors? - The Motley Fool
PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
The Gross Law Firm Reminds PROCEPT BioRobotics Corporation Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2026PRCT - Morningstar
PRCT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm Before Lead Plaintiff Deadline on September 22, 2026 - The Globe and Mail
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with SBS Law - GlobeNewswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against PROCEPT BioRobotics Corporation (PRCT) - TMX Newsfile
Attention Long-Term Shareholders of Cogent Communications - GlobeNewswire
PRCT INVESTOR ALERT: PROCEPT BioRobotics Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
PROCEPT BioRobotics(R) to Attend the Baird 2026 Global Healthcare Conference on September 15, 2026 - marketscreener.com
GSA Capital Partners LLP Purchases New Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PRCT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PROCEPT BioRobotics Corporation Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
PROCEPT BioRobotics Corporation (PRCT) Investors: September - GlobeNewswire
Robbins LLP Encourages PRCT Shareholders With Significant Losses to Contact the Firm for Information About the Class Action Against PROCEPT BioRobotics Corporation - Business Wire
Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm to Learn About Their Legal Rights - The Globe and Mail
Deadline Alert: PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - GlobeNewswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
Kaplan Fox Alerts PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Who Suffered Losses to a Securities Class Action – Deadline is September 22, 2026 - The Spec
PROCEPT BioRobotics® to Attend the Baird 2026 Global Healthcare Conference on September 15, 2026 - The Manila Times
The Bull Case For PROCEPT BioRobotics (PRCT) Could Change Following Q2 Losses Amid Strong Revenue Growth - simplywall.st
PRCT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PROCEPT BioRobotics Corporation Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
PRCT Deadline: PRCT Investors with Losses in Excess of $100K Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit - PR Newswire
Johnson & Johnson Invests $8.08 Billion in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics Investors: September 22, 2026, Deadline in Securities Fraud Class Action Lawsuit - NewMediaWire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages PROCEPT BioRobotics Corporation Investors to Secure ... - Caledonian Record
PROCEPT BioRobotics EVP Alaleh Nouri Granted 22,965 RSUs and Stock Options for 31,773 Shares - Kalkine Media
PROCEPT BioRobotics CTO Barry Templin Awarded RSUs and Stock Options in Advance of 2027 Grants - Kalkine Media
PROCEPT BioRobotics (PRCT) awards RSUs and stock options to EVP and CLO - Stock Titan
Procept Biorobotics Corp Stock (PRCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.32%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):